In an in-depth interview with healthcare innovation website Cure, Ben Dibling, PhD, Associate Vice Provost for Research and Managing Director of PCI, discusses when publication-only or publication-plus makes sense with respect to research findings, when licensing to an established company is the right approach for commercialization, and when it may be more appropriate to advance the technology by spinning out a startup company. Read the full interview here.